The Third Annual Wednesday Liver Symposium: The Dawn of a New Era in Precision Medicine: NIT for Cirrhosis and Reasonably likely Surrogate Endpoints, will take place on Wednesday, November 4, 2026, in Denver, CO. Directed by Dr. Rohit Loomba, this high-impact, one-day symposium will bring together leading experts in hepatology, clinical trials, genetics, and biomarker development to explore transformative advances in diagnosing and managing liver disease. With a robust agenda spanning genetic risk stratification, non-invasive imaging, biomarker integration into therapeutic trials, and regulatory perspectives, the symposium aims to define the current landscape, identify research priorities, and foster collaboration across academic, clinical, biotech, and regulatory communities to accelerate progress in treating and managing Metabolic Dysfunction-Associated Steatohepatitis (MASH), cirrhosis, and related liver disorders.